Back
Cue Biopharma Quote, Financials, Valuation and Earnings
Sponsored
CUE
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
54
CUE
Cue Biopharma
Last Price:
1.51
Seasonality Move:
5.19%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Cue Biopharma Price Quote
$1.51
+0.01 (+0.67%)
(Updated: November 15, 2024 at 3:36 AM ET)
Cue Biopharma Key Stats
Buy
54
Cue Biopharma (CUE)
is a Buy
Day range:
$1.45 - $1.60
52-week range:
$0.45 - $3.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.73
P/B ratio:
4.18%
Volume:
1.3M
Avg. volume:
1.1M
1-year change:
-39.02%
Market cap:
$90.3M
Revenue:
$5.5M
EPS:
$-0.98
How Much Does Cue Biopharma Make?
-
How Much Are Cue Biopharma's Sales Annually?
CUE Revenues are $5.5M -
How Much Profit Does Cue Biopharma's Make A Year?
CUE net income is -$50.7M
Is Cue Biopharma Growing As A Company?
-
What Is Cue Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.92% -
What Is Cue Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Cue Biopharma Stock Price Performance
-
Did Cue Biopharma Stock Go Up Last Month?
Cue Biopharma share price went up by 23.97% last month -
Did CUE's Share Price Rise Over The Last Year?
CUE share price fell by -39.02% over the past 1 year
What Is Cue Biopharma 52-Week High & Low?
-
What Is Cue Biopharma’s 52-Week High Share Price?
Cue Biopharma has traded as high as $3.25 over the past 52 weeks -
What Is Cue Biopharma’s 52-Week Low Share Price?
Cue Biopharma has traded as low as $0.45 over the past 52 weeks
Cue Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Cue Biopharma?
-
How Much Debt Does Cue Biopharma Have?
Total long term debt quarterly is $6.2M -
How Much Cash Does Cue Biopharma Have?
Cash and short term investments quarterly total is $30M -
What Is Cue Biopharma’s Book Value Per Share?
Book value per share is 0.44
Is Cue Biopharma Cash Flow Positive?
-
What Is CUE Cash Flow From Operations?
Cash flow from operations (TTM) is -$38.5M -
What Is Cue Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.7M -
What Is Cue Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4.9M
Cue Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
CUE return on invested capital is -107.58% -
What Is Cue Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -78.3% -
What Is CUE Return On Equity?
ROE is a measure of profitability and is -132.34%
Cue Biopharma Earnings Date & Stock Price
-
What Is Cue Biopharma's Stock Price Today?
A single share of CUE can be purchased today for 1.50 -
What Is Cue Biopharma’s Stock Symbol?
Cue Biopharma trades on the nasdaq under the ticker symbol: CUE -
When Is Cue Biopharma’s Next Earnings Date?
The next quarterly earnings date for Cue Biopharma is scheduled on November 15, 2024 -
When Is CUE's next ex-dividend date?
Cue Biopharma's next ex-dividend date is May 26, 2020 -
How To Buy Cue Biopharma Stock?
You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Cue Biopharma Competitors
-
Who Are Cue Biopharma's Competitors?
Below is a list of companies who compete with Cue Biopharma or are related in some way:
Cue Biopharma Dividend Yield
-
What Is CUE Dividend Yield?
Cue Biopharma’s dividend yield currently is 0% -
What Is Cue Biopharma’s Payout Ratio?
Cue Biopharma’s payout ratio is 0% -
When Did Cue Biopharma Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Cue Biopharma’s Dividend Per Share?
Cue Biopharma pays a dividend of $0.00 per share
Cue Biopharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 28.57% |
Revenue: | 92.33% | 106.21% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 4.00 |
Upside from Last Price: | 166.67% |